Evolus (EOLS) Insider Trading & Ownership $10.24 +0.37 (+3.75%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$10.24 0.00 (0.00%) As of 05:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evolus (NASDAQ:EOLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$189KNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.23M Get EOLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Evolus stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EOLS Insider Buying and Selling by Quarter Evolus Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/9/2025Albert G White IIIDirectorBuy20,000$9.45$189,000.00 5/13/2025Sandra BeaverCFOSell6,494$10.02$65,069.88 5/12/2025David MoatazediInsiderSell15,787$9.87$155,817.69 5/12/2025Rui AvelarInsiderSell3,385$9.87$33,409.95 3/27/2025David MoatazediInsiderSell6,251$12.40$77,512.40 3/18/2025Rui AvelarInsiderSell27,904$13.26$370,007.04 3/18/2025Sandra BeaverCFOSell8,996$13.26$119,286.96 3/18/2025Tomoko Yamagishi-DresslerCMOSell4,536$13.26$60,147.36 3/12/2025Karah Herdman ParschauerDirectorSell12,888$12.99$167,415.12 12/23/2024Rui AvelarInsiderSell2,252$10.85$24,434.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/23/2024Sandra BeaverCFOSell1,586$10.85$17,208.10 9/6/2024Sandra BeaverCFOSell3,276$14.98$49,074.48 8/30/2024Tomoko Yamagishi-DresslerCMOSell5,631$15.85$89,251.35 (Data available from 1/1/2013 forward) EOLS Insider Trading Activity - Frequently Asked Questions Who is on Evolus's Insider Roster? The list of insiders at Evolus includes Albert G White III, Alphaeon 1 Llc, David Moatazedi, David N Gill, Karah Herdman Parschauer, Medytox Inc., Robert Hayman, Rui Avelar, Sandra Beaver, Tomoko Yamagishi-Dressler, and Vikram Malik. Learn more on insiders at EOLS. What percentage of Evolus stock is owned by insiders? 5.90% of Evolus stock is owned by insiders. Learn more on EOLS's insider holdings. Which Evolus insiders have been buying company stock? The following insiders have purchased EOLS shares in the last 24 months: Albert G White III ($189,000.00), and Vikram Malik ($1,296,505.47). How much insider buying is happening at Evolus? Insiders have purchased a total of 194,967 EOLS shares in the last 24 months for a total of $1,485,505.47 bought. Which Evolus insiders have been selling company stock? The following insiders have sold EOLS shares in the last 24 months: David Moatazedi ($3,453,566.33), David N Gill ($46,338.96), Karah Herdman Parschauer ($324,188.46), Medytox Inc. ($12,679,972.50), Rui Avelar ($834,791.92), Sandra Beaver ($415,059.50), Tomoko Yamagishi-Dressler ($149,398.71), and Vikram Malik ($97,200.00). How much insider selling is happening at Evolus? Insiders have sold a total of 2,123,550 Evolus shares in the last 24 months for a total of $18,000,516.38 sold. Evolus Key ExecutivesMr. David Moatazedi (Age 46)President, CEO & Director Compensation: $1.75M2 recent tradesMs. Sandra Beaver (Age 46)Chief Financial Officer Compensation: $740.15k3 recent tradesDr. Rui Avelar C.CFP (Age 62)Dip.SportMed, M.D., Chief Medical Officer and Head of Research & Development Compensation: $823.19kMr. Nareg SagherianHead of Global Investor Relations & Corporate CommunicationsMr. Jeffrey J. PlumerGeneral CounselMr. Kurt KnabVice President of SalesMs. Tomoko Yamagishi-DresslerChief Marketing Officer1 recent tradesMs. Jessica NovakSenior Vice President of Human Resources More Insider Trading Tools from MarketBeat Related Companies LYEL Insider Ownership APLS Insider Ownership OGN Insider Ownership IBRX Insider Ownership AMRX Insider Ownership XENE Insider Ownership MIRM Insider Ownership ARWR Insider Ownership NAMS Insider Ownership HRMY Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite Disparity This page (NASDAQ:EOLS) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.